Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

NCT01491594 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Unable to accrue subjects to the study.

Conditions

Sarcoma, Soft Tissue
Osteosarcoma
Neoplasms, Connective and Soft Tissue

Interventions

DRUG: Eltrombopag

Sponsor

Duke University

Collaborators

[object Object]